MLSC International Collaborative Industry Program: Phase I Deadline

Monday, September 16 2013
10:00 am

Location: 1000 Winter Street (South Entrance), Waltham

Through the new International Collaborative Industry Program (ICIP), the MLSC is partnering with Victoria, Australia; the Wallonia region of Belgium; Quebec, Canada; and Alsace in France to award funding to support winning projects demonstrating innovative and collaborative research and development (R & D) in Massachusetts and in the partnering regions. Companies from biotechnology, pharmaceuticals, medical devices, diagnostics and bioinformatics are eligible to submit collaborative project applications.

An eligible project will be in late-stage R & D, and will consist of one Massachusetts company and one company from one of the four international partner regions. Winning partners emerging from this competitive process will each be funded by an agency in their own geography.

During this inaugural round of ICIP, the MLSC Board of Directors has authorized a total of up to $1.5 million for winning Massachusetts companies. Grants will range from a minimum of $100,000 to a maximum of $500,000, and companies will match the funding that MLSC provides. The international agency will fund their local company winners. The Phase I project applications are due on September 16, 2013, at 10 a.m. EDT, and announcement of the winners is expected in March, 2014.

For more information about ICIP, visit http://www.masslifesciences.com/icip.html. If you have any questions after reviewing the information posted, please contact icip@masslifesciences.com.

To register for this information session, please click here.

Share MassBio

 

EvaluatePharma

MassBio